Literature DB >> 7917074

Review of clinically important drug interactions with lithium.

N S Harvey1, S Merriman.   

Abstract

The therapeutic dosage of lithium is close to the toxic level, and drugs reducing the renal clearance of lithium can produce the most serious adverse effects. When used in combination with psychiatric drugs affecting mood, the therapeutic potential of lithium may be enhanced, and earlier concern regarding possible neurotoxic interactions with neuroleptics appear poorly substantiated. A number of specific interactions of low incidence have also been reported which should be borne in mind when new medications are introduced. The ready availability of lithium concentration monitoring in body fluids makes it possible to alter the effects of some potentially interactive drugs that may still need to be given in combination with lithium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917074     DOI: 10.2165/00002018-199410060-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  90 in total

1.  Letter: Lithium levels and "Soda Bic".

Authors:  R K Arthur
Journal:  Med J Aust       Date:  1975-12-13       Impact factor: 7.738

2.  Letter: Adverse interaction of lithium carbonate and methyldopa.

Authors:  J B O'Regan
Journal:  Can Med Assoc J       Date:  1976-09-04       Impact factor: 8.262

3.  [Use of combined complexes and lithium carbonate in the preoperative care of patients with toxic goiter].

Authors:  M I Slobozhanin; V S Chudnova; I S Kuznetsov
Journal:  Klin Khir       Date:  1989

4.  Possible synergism between iodine and lithium carbonate.

Authors:  J V Jorgensen; F Brandrup; M Schroll
Journal:  JAMA       Date:  1973-01-08       Impact factor: 56.272

5.  The effect of prolonged administration of hydrochlorothiazide on the renal lithium clearance and the urine flow of ordinary rats and rats with diabetes insipidus.

Authors:  K Thomsen; M Schou
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1973-09

6.  Manic response to levodopa therapy. Report of a case.

Authors:  R S Ryback; R S Schwab
Journal:  N Engl J Med       Date:  1971-09-30       Impact factor: 91.245

7.  Antagonism of cocaine highs by lithium.

Authors:  A J Cronson; A Flemenbaum
Journal:  Am J Psychiatry       Date:  1978-07       Impact factor: 18.112

8.  Interaction of lithium and phenytoin.

Authors:  W A MacCallum
Journal:  Br Med J       Date:  1980-03-01

9.  Control of lithium tremor with propranolol.

Authors:  Y D Lapierre
Journal:  Can Med Assoc J       Date:  1976-04-03       Impact factor: 8.262

10.  Persisting neurologic sequelae of lithium carbonate therapy.

Authors:  I M Donaldson; J Cuningham
Journal:  Arch Neurol       Date:  1983-11
View more
  4 in total

Review 1.  Lithium and the kidney: an updated review.

Authors:  M Gitlin
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

2.  The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium.

Authors:  G Apseloff; D Mullet; K D Wilner; R J Anziano; T G Tensfeldt; S M Pelletier; N Gerber
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

Review 3.  Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 4.  Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.